InterCure Schedules Third Quarter 2021 Financial Results Conference Call

Rhea-AI Summary

InterCure (NASDAQ: INCR) is set to release its third-quarter financial results on November 16, 2021, before the market opens. A conference call will follow at 8:30 AM ET, discussing the results and the company's growth strategy. InterCure, operating under the brand Canndoc, is Israel's largest licensed cannabis producer and claims to be the fastest-growing cannabis company outside North America. The firm has a vertically integrated model, ensuring high-margin operations.

Positive

• InterCure is recognized as the fastest growing cannabis company outside North America.
• The company is profitable and has a leading distribution network in Israel.

Negative

• None.

Call Scheduled for Tuesday, November 16, 2021 at 8:30 am ET

NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 11, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the third quarter of 2021 before market open on Tuesday, November 16, 2021. The Company will conduct a conference call on Tuesday, November 16, 2021 at 8:30 a.m. (Eastern Time) to review the results as well as provide an overview of the Company’s recent milestones and growth strategy.

To access the conference call, United States participants please dial 1-877-705-6003, or for international callers, 1-201-493-6725. A replay will be available shortly after the call, United States participants can access the replay by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13725075. The replay will be available until November 30, 2021.

A live webcast of the conference call can be accessed on the ‘Events and Presentations’ section of the InterCure website at http://www.intercure.co. An online archive of the webcast will be available on the Company’s website for 30 days following the call.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

To be added to InterCure’s email distribution list, please email InterCure@kcsa.com with “InterCure” in the subject.

Contact:

InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@canndoc-pharma.com

KCSA Strategic Communications
Investor and Media Relations
InterCure@kcsa.com

FAQ

What is the date for InterCure's Q3 2021 financial results release?

InterCure will release its Q3 2021 financial results on November 16, 2021.

What time is InterCure's conference call scheduled?

The conference call is scheduled for 8:30 AM ET on November 16, 2021.

How can I access the live webcast of InterCure's conference call?

The live webcast can be accessed on the 'Events and Presentations' section of InterCure's website.

Who is InterCure's subsidiary that produces cannabis?

InterCure's subsidiary that produces cannabis is called Canndoc.

Is InterCure a profitable company?

Yes, InterCure is recognized as a profitable company in the cannabis industry.